Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Hester Biosciences Ltd Board/Management Information 2019

Jan 21, 2019

62222_rns_2019-01-21_36fdbaec-c8b9-45d3-80de-6fa6728edeac.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [525 x 97] intentionally omitted <==

21 January 2019

To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai 400 001

Scrip Code: 524669

To, National Stock Exchange of India Limited Exchange Plaza, Bandra - Kurla Complex, Bandra (E), Mumbai 400 051

Symbol: HESTERBIO

Respected Sir / Madam:

Subject: Intimation for the Board Meeting to be held on 29 January 2019

This is to inform you that as per Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a Meeting of the Board of Directors of the Company will be held on Tuesday, 29 January 2019 at 10.30 am at its Registered Office at 1[st] Floor, Pushpak, Panchvati Circle, Motilal Hirabhai Road, Ahmedabad 380006, to consider the Unaudited Standalone Financial Results for the quarter and nine months ended on 31 December 2018.

Please also take a note that in compliance with SEBI (Prohibition of Insider Trading) Regulations, read with code of conduct of the Company, the “Trading Window” for dealing in equity shares of the Company shall remain closed from 21 January 2019 and will end 48 hours after the financial results are made public on 29 January 2019.

We request you to take note of the above.

Sincerely For Hester Biosciences Limited Rajiv Gandhi CEO & Managing Director DIN: 00438037